Insider Trading & Executive Data
Start Free Trial
283 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Jackson Financial Inc. is a U.S.-focused retirement solutions company that designs, distributes and administers annuities and related life insurance products, with AUM of ~$324.7B (2024) and retail annuity sales of $17.8B in 2024. Key capabilities sit in its in‑house investment managers (JNAM and PPM) and a scalable administration platform that handles ~79% of in‑force policies; management emphasizes product pricing, actuarial discipline and a two‑tier hedging program supplemented by reinsurance (notably the Brooke Re coinsurance transaction). Management uses Adjusted Operating Earnings as its primary performance metric to strip out large GAAP volatility from derivatives and actuarial reserve changes, while statutory capital (RBC ~572% at 12/31/2024) and liquidity are material oversight points. The business is sensitive to market/interest‑rate moves, hedging effectiveness, and distribution partner dynamics (independent broker‑dealers, wirehouses, banks, RIAs and institutional channels).
Compensation at Jackson is likely to emphasize metrics that reflect the company’s core drivers—Adjusted Operating Earnings, adjusted operating ROE, spread income, AUM/retail annuity sales and effective hedging/claims outcomes—rather than volatile GAAP net income. The MD&A notes higher commissions and incentive compensation in 2024, implying significant variable pay for sales and distribution leaders (wholesalers and channel managers) and performance‑based bonuses for investment and actuarial teams tied to hedging efficiency and actuarial assumption outcomes. Given the regulatory and capital sensitivity, executives’ long‑term incentive pay is likely to include deferred equity, performance shares tied to multi‑year capital generation targets and risk‑adjusted metrics, plus clawback features or compensation adjustments to align pay with statutory capital and risk outcomes. Expect routine equity grants and tax‑related sales by insiders (to cover withholding) but also structural limits (vesting schedules, deferrals and potential forfeiture) intended to preserve capital and align with multi‑year risk management.
Watch for insider activity clustered around a handful of high‑impact events: quarterly/annual releases that disclose Adjusted Operating Earnings versus GAAP volatility, actuarial assumption updates, major reinsurance/coinsurance closings (e.g., Brooke Re), and capital‑return announcements (dividends/buybacks), since these materially affect perceived capital adequacy and valuation. Because compensation includes equity and performance awards, Form 4 filings for option/RSU grants and routine sales to cover taxes are common—look for opportunistic sales after strong operating prints or capital return guidance, and purchases when statutory capital or free cash flow guidance improves. Regulatory and compliance frameworks (Section 16 reporting, Rule 10b5‑1 plans, state insurance dividend restrictions and holding‑company liquidity constraints) shape blackout periods and pre‑clearance behavior, and the firm’s heavy derivatives/reinsurance profile increases the chance of sudden GAAP swings that can prompt cautious insider trading windows.